recover. Similar findings have been reported for BK virus, a related polyomavirus that infects transplant recipients. 4 Multiple sclerosis is a serious and disabling neurologic disease with limited therapeutic options. Since the suspension of natalizumab, we have heard expressions of frustration and disappointment from patients and others in the multiple sclerosis community. We understand that for many, natalizumab provided new hope for the management of this difficult disease; given these events and the efficacy and otherwise good safety profile of natalizumab, the importance of better defining potential risks of its use will be key to understanding its place in therapeutics.
We thank patients, physicians, and the entire multiple sclerosis community for their continued patience and support during the past few months. We remain firmly committed to a thorough evaluation of the safety profile of natalizumab so that we may provide physicians and patients with the necessary information to make informed benefit-risk decisions about their multiple sclerosis therapy.
